Efficacy and Safety of Torasemide in Patients with Mild to Moderate Essential Hypertension
苏绮,李一石,陈君柱,黄德嘉,樊朝美,孙兴昌,胡晓晟,陈晓平,龚培,成小如,华潞
DOI: https://doi.org/10.3969/j.issn.1673-7245.2003.04.014
2003-01-01
Abstract:Objective To evaluate the antihypertensive effect and safety of torasemide in Chinese patients with mild to moderate essential hypertension Methods After 1～2 weeks wash out, patients with mild to moderate essential hypertension(seated DBP 95～115 mmHg), were randomly assigned to received torasemide 5 mg or indapamide 2 5 mg once a day for 4 weeks, followed by a double dose for another 4 weeks in patients whose seated DBP were still ≥90 mmHg Blood pressure, heart rate, symptoms and signs were examined at the end of wash out and 2, 4, 6, 8 weeks Laboratory examinations were performed at baseline, 2 weeks and the end of the trial Results 130 essential hypertensive patients were recruited and randomized to receive either torasemide group ( n =64) or indapamide group ( n =66) 118 patients completed the trial, 56 patients in torasemide group(30 finished at the end of 4 weeks and 26 finished at the end of 8 weeks) and 62 in indapamide group(41 finished at the end of 4 weeks and 21 finished at the end of 8 weeks) At the end of 4 weeks, the effective rate was 67 86% in torasemide group and 72 58% in indapamide group At the end of 8 weeks, the effective rate in those whose dosage was doubled was 34 62% in torasemide group and 61 90% in indapamide group No statistical difference was found ( P =0 67) The decrease of seated DBP was of no differece between the two groups at the end of 2, 4, 6, 8 weeks The values of serum potassium, sodium, chloride were lower in indapamide group than those in torasemide group at 2 weeks and the end of the trial ( P 0 01 or P 0 05) Conclusion Torasemide 5 mg/d～10 mg/d is as effective as indapamide 2 5 mg/d～5 mg/d in patients with mild to moderate essential hypertension The impact of torasemide to serum electrolyte is much less than that of indapamide